Videos
TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment
Torsten Vahl, Rebecca Hahn, Vinod Thourani, Raj Makkar and Marty Leon discuss TAVR for Aortic Regurgitation at TCT 2022.
Latest News
View All
Press
April 1, 2026
JenaValve Announces Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the US
Read More
Press
March 18, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
Read More
Press
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More